US-Mexico USMCA Talks Advance as Auto Rules Remain Major Sticking Point 
Russia Says It Hit Ukrainian Ports, Cargo Ships in Odesa and Chornomorsk 
Trump Praises Nigeria’s Tinubu, Signaling Stronger U.S.-Nigeria Security Ties 
EEOC Drops Penn Subpoena in Antisemitism Probe, Investigation Continues 
Zelenskiy Says Ukraine-U.S. Drone Deal Includes American Factory for Advanced UAV Production 
Trump Administration Opens Civil Rights Probes Into Five U.S. Medical Schools Over Admissions 
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship 
Russian Bomb Strikes Hit Zaporizhzhia, Sloviansk, Injuring Dozens in Eastern Ukraine 
Russian Missile Strike on Kyiv Region Kills 10, Sparks Probe Into Defense Industry Event 
Canada Vows Trade Fight as Trump Imposes 50% Tariffs 
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access 
Trump Says No Decision on Major Iran Strikes as U.S.-Tehran Talks Intensify 
Trump Signals More Iran Strikes While Leaving Door Open to Nuclear Deal 
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access 
UN Reappoints Volker Turk as Human Rights Chief Despite U.S., Russia, Israel Opposition 
Appeals Court Rejects Trump Bid to Reinstate $100,000 H-1B Visa Fee 
U.S. President Donald Trump asked the help of American pharmaceutical firms that are currently working on experimental COVID-19 treatments to offer their drugs to Boris Johnson. The British Prime Minister has been moved to the I.C.U. after his coronavirus symptoms worsened.
“I’ve asked two of the leading companies,” Donald Trump said during a press conference, The Guardian reported. “They’ve come with the solutions and just have done incredible jobs – and I’ve asked him to contact London immediately.”
Trump said that the drugs are already in London and ready for use. “They’ve really advanced therapeutics … and they have arrived in London already,” the U.S. President said. “The London office has whatever they need. We’ll see if we can be of help. We’ve contacted all of Boris’s doctors, and we’ll see what is going to take place, but they are ready to go.”
The President did not specifically mention the name of the drugs or the pharmaceutical companies that made them. However, The Guardian noted that Trump had an earlier conference with the heads of biotech and pharmaceutical firms Amgen, Genetech, Gilead and Regeneron, pointed out that
However, Trump revealed that it’s still not certain if Boris Johnson would opt for the experimental treatments. “They’ve had meetings with the doctors, and we’ll see whether or not they want to go that route,” he said. “But when you’re in intensive care it’s a big deal. So they’re there and they’re ready.”
Donald Trump expressed sadness over what happened to his British counterpart, whom he considers to be one of his closest allies. “We’re very saddened to hear that he was taken into intensive care this afternoon, a little while ago, and Americans are all praying for his recovery,” Trump said. “He’s been a really good friend. He’s been really something very special: strong, resolute, doesn’t quit, doesn’t give up.”
Johnson has been moved to intensive care on Monday afternoon after his symptoms worsened, according to BBC. “Over the course of [Monday] afternoon, the condition of the prime minister has worsened and, on the advice of his medical team, he has been moved to the intensive care unit at the hospital,” a statement from No. 10 Downing Street reads.
